2. Academic Validation
  3. N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity

N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity

  • J Med Chem. 2021 Dec 23;64(24):18010-18024. doi: 10.1021/acs.jmedchem.1c01377.
Sharanbasappa S Karade 1 2,  Michelle L Hill 3,  J L Kiappes 4,  Rajkumar Manne 5,  Balakishan Aakula 5,  Nicole Zitzmann 3,  Kelly L Warfield 6,  Anthony M Treston 6,  Roy A Mariuzza 1 2
Affiliations

Affiliations

  • 1 University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, Maryland 20850, United States.
  • 2 Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland 20742, United States.
  • 3 Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, U.K.
  • 4 Department of Chemistry, University College, London WC1H 0AJ, U.K.
  • 5 Sai Life Sciences Ltd., Hyderabad, 500032 Telangana, India.
  • 6 Emergent BioSolutions, Gaithersburg, Maryland 20879, United States.
PMID: 34870992 DOI: 10.1021/acs.jmedchem.1c01377
Abstract

Most enveloped viruses rely on the host cell endoplasmic reticulum (ER) quality control (QC) machinery for proper folding of glycoproteins. The key ER α-glucosidases (α-Glu) I and II of the ERQC machinery are attractive targets for developing broad-spectrum antivirals. Iminosugars based on deoxynojirimycin have been extensively studied as ER α-glucosidase inhibitors; however, Other glycomimetic compounds are less established. Accordingly, we synthesized a series of N-substituted derivatives of valiolamine, the iminosugar scaffold of type 2 diabetes drug voglibose. To understand the basis for up to 100,000-fold improved inhibitory potency, we determined high-resolution crystal structures of mouse ER α-GluII in complex with valiolamine and 10 derivatives. The structures revealed extensive interactions with all four α-GluII subsites. We further showed that N-substituted valiolamines were active against Dengue virus and SARS-CoV-2 in vitro. This study introduces valiolamine-based inhibitors of the ERQC machinery as candidates for developing potential broad-spectrum therapeutics against the existing and emerging viruses.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z